Serum Fork-Head Box D3 (FOXD3) Expression Is Down-Regulated in and Associated with Diagnosis of Patients with Non-Small Cell Lung Cancer

@inproceedings{Xu2018SerumFB,
  title={Serum Fork-Head Box D3 (FOXD3) Expression Is Down-Regulated in and Associated with Diagnosis of Patients with Non-Small Cell Lung Cancer},
  author={Bao-Ning Xu and Lei Zhang and Dan-dan Zhang and Cheng-Yang Song and Da-Li Tian and Wen-jun Jiang},
  booktitle={Medical science monitor : international medical journal of experimental and clinical research},
  year={2018}
}
BACKGROUND The aim of this study was to detect the expression of fork-head box D3 (FOXD3) and investigate its diagnostic value in patients with non-small cell lung cancer (NSCLC). MATERIAL AND METHODS The relative expression of FOXD3 at mRNA and protein levels was determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting analysis, respectively. Chi-square test was used to explore the relevance of FOXD3 expression with clinical features of NSCLC… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Global cancer statistics Prognostic significance of tumor - infiltrating CD 8 ( + ) or CD 3 ( + ) T lymphocytes and interleukin - 2 expression in radically resected non - small cell lung cancer

Y Ou, Y Ma
  • Chin Med J ( Engl )
  • 2015

Similar Papers

Loading similar papers…